These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 20980063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.
    Kazantsev AG, Thompson LM.
    Nat Rev Drug Discov; 2008 Oct; 7(10):854-68. PubMed ID: 18827828
    [Abstract] [Full Text] [Related]

  • 4. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
    Anne-Laurence B, Caroline R, Irina P, Jean-Philippe L.
    Subcell Biochem; 2007 Oct; 41():263-93. PubMed ID: 17484132
    [Abstract] [Full Text] [Related]

  • 5. [EPIGENETIC ENZYMES AS THERAPEUTIC TARGETS FOR TREATING BRAIN DISORDERS].
    Gomazkov OA.
    Eksp Klin Farmakol; 2015 Oct; 78(11):35-44. PubMed ID: 27017704
    [Abstract] [Full Text] [Related]

  • 6. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?
    Grayson DR, Kundakovic M, Sharma RP.
    Mol Pharmacol; 2010 Feb; 77(2):126-35. PubMed ID: 19917878
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitors in cancer therapy.
    Lane AA, Chabner BA.
    J Clin Oncol; 2009 Nov 10; 27(32):5459-68. PubMed ID: 19826124
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic regulation of airway inflammation.
    Adcock IM, Tsaprouni L, Bhavsar P, Ito K.
    Curr Opin Immunol; 2007 Dec 10; 19(6):694-700. PubMed ID: 17720468
    [Abstract] [Full Text] [Related]

  • 9. HDAC modulation and cell death in the clinic.
    Dell'Aversana C, Lepore I, Altucci L.
    Exp Cell Res; 2012 Jul 01; 318(11):1229-44. PubMed ID: 22336671
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z, Barile FA.
    J Pharmacol Toxicol Methods; 2012 Jul 01; 66(3):215-20. PubMed ID: 22902970
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Histone deacetylases in memory and cognition.
    Penney J, Tsai LH.
    Sci Signal; 2014 Dec 09; 7(355):re12. PubMed ID: 25492968
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inside HDAC with HDAC inhibitors.
    Bertrand P.
    Eur J Med Chem; 2010 Jun 09; 45(6):2095-116. PubMed ID: 20223566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.